Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, ...

The Eras Tour singer met the young girl when she made a surprise visit to the hospital on Dec. 12, the day before her 35th ...

"I wanted to share something about Ana that only a few of us still remember. Ana was here. She was amazing. She invented ...

Hims & Hers Health (NYSE: HIMS) stock is on a downward trend on both macro trends and news about GLP-1s. But this is still a ...

Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no ...

The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli Lilly's weight ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated ...

Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS ...

I always imagine there’s a little bird trying to take flight. That’s what I felt for season two: She was just trying to fly, ...

In terms of liquidity and interest, the mean open interest for Hims & Hers Health options trades today is 3348.53 with a ...

Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on Hims & Hers Health (HIMS – Research Report), retaining the ...

Hims & Hers Health (HIMS) shares tumble after the US Food and Drug Administration (FDA) announced that the shortage in Eli ...